2021
DOI: 10.1016/j.biomaterials.2021.120788
|View full text |Cite
|
Sign up to set email alerts
|

Black phosphorous nanosheet: A novel immune-potentiating nanoadjuvant for near-infrared-improved immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 43 publications
(31 citation statements)
references
References 53 publications
0
29
0
2
Order By: Relevance
“…However, ~ 80% patients were suffered from tumor recrudescence after thermotherapy [ 45 ]. Nanomaterials have recently been reported to active the immunity system and cause specific immune effects alongside the physical ablation by heat, suggesting their potential reduction on tumor recrudescence [ 46 , 47 ]. Based on this, comprehensive investigations on the specific immune responses of nanomaterials on the liver cancer should be conducted.…”
Section: Resultsmentioning
confidence: 99%
“…However, ~ 80% patients were suffered from tumor recrudescence after thermotherapy [ 45 ]. Nanomaterials have recently been reported to active the immunity system and cause specific immune effects alongside the physical ablation by heat, suggesting their potential reduction on tumor recrudescence [ 46 , 47 ]. Based on this, comprehensive investigations on the specific immune responses of nanomaterials on the liver cancer should be conducted.…”
Section: Resultsmentioning
confidence: 99%
“…As an essential component in most vaccines, adjuvant can enhance the immunogenicity of antigen via various ways. [14][15][16] Agonist-induced STING activation in antigen-presenting cells (APCs) not only generates IFN-β and other pro-inflammatory cytokines, but also upregulates the costimulatory signals (CD86, CD80 and CD40) and major histocompatibility complex (MHC) class I/II. These characteristics are exactly what is required for the efficient presentation of vaccine antigens and T cell immunity induction.…”
Section: Vaccine Adjuvantmentioning
confidence: 99%
“…The combined cancer treatment modality can both improve their therapeutic efficacy and lower side effects. PTT/IT BPNSs-DcF@sPL Circumvent PL pathway-regulated immune tolerance and suppression of CD8 + T cells, enhance the IFN-γ expression and promote the survival rate [131] FKF-OVAp@BPNSs Enhance antigen uptake, activate systemic immunity and prolong the survival time [135] BPNSs-bPEI-PEG-CpG Induce necroptotic cell death, activate T lymphocytes, increase serum IL-2, TNF-α and IFN-γ level, suppress both primary and distal tumors [138] hEX@BPNSs Activate immune system, inhibit tumor progression and prolong survival [141] BPNSs + aCD47…”
Section: Synergistic Cancer Photoimmunotherapy Based On Black Phosphorus Nanomaterialsmentioning
confidence: 99%
“…Thus, BP can be harnessed as an adjuvant for antigen delivery. Here, OVAp and phenylalanine-lysine-phenylalanine (FKF) were integrated onto the surface of BP nanomaterials to obtain nanovaccines termed as FKF-OVAp@BP [ 135 ]. Within tumor mild acidic environment, the electrostatic interaction between lysine and BP nanomaterials was disturbed, subsequently inducing the dissociation of antigen FKF peptide from BP nanomaterials, which enabled OVAp-mediated antigen-specific immune responses regardless of in vitro or in vivo administration.…”
Section: Delivery Of Immunotherapeutic Agents For Cancer Immunotherapymentioning
confidence: 99%